Position in CELU
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,409
-$32,327 QoQ
Shares Held
44,163
0.0% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 39 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. CELU ranks #402 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CELU
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,409 | 44,163 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $58,736 | 44,163 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $49,020 | 44,163 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $70,508 | 34,062 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $66,761 | 34,062 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $58,927 | 34,062 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $70,848 | 34,062 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $101,164 | 34,062 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $106,614 | 34,062 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $143,014 | 27,345 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $34,147 | 138,248 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,691 | 138,248 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $73,686 | 138,248 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $319,993 | 516,120 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $708,865 | 549,508 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,294,767 | 560,506 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $371,554 | 109,281 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||